CellSource Co (TSE:4880) Total Liabilities : 円847 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Total Liabilities?

CellSource Co's Total Liabilities for the quarter that ended in Jan. 2024 was 円847 Mil.

CellSource Co's quarterly Total Liabilities increased from Jul. 2023 (円530.39 Mil) to Oct. 2023 (円677.74 Mil) and increased from Oct. 2023 (円677.74 Mil) to Jan. 2024 (円846.64 Mil).

CellSource Co's annual Total Liabilities increased from Oct. 2021 (円645.00 Mil) to Oct. 2022 (円814.15 Mil) but then declined from Oct. 2022 (円814.15 Mil) to Oct. 2023 (円677.74 Mil).

CellSource Co Total Liabilities Historical Data

The historical data trend for CellSource Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Total Liabilities Chart

CellSource Co Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Total Liabilities

Get a 7-Day Free Trial

234.54

309.63

645.00

814.15

677.74

CellSource Co Quarterly Data
	Oct18	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Liabilities	Get a 7-Day Free Trial															410.95	610.74	530.39	677.74	846.64

CellSource Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

CellSource Co's Total Liabilities for the fiscal year that ended in Oct. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	452.156	+	(77.291	+	148.292
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	678

Total Liabilities	=	Total Assets (A: Oct. 2023 )	-	Total Equity (A: Oct. 2023 )
	=	6879.736	-	6201.997
	=	678

CellSource Co's Total Liabilities for the quarter that ended in Jan. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	626.185	+	(0	+	220.457
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	847

Total Liabilities	=	Total Assets (Q: Jan. 2024 )	-	Total Equity (Q: Jan. 2024 )
	=	6807.595	-	5960.953
	=	847

CellSource Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of CellSource Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

CellSource Co (TSE:4880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002

Website

https://www.cellsource.co.jp

CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines